Related Experiment Video

Updated: Aug 7, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells

Rita Nahta1, Linda X H Yuan, Derek J Fiterman

  • 1Department of Breast Medical Oncology, Unit 1354, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. rnahta@mdanderson.org

Molecular Cancer Therapeutics
|July 5, 2006
PubMed

Insights

Antisense Bcl-2 oligonucleotides induce breast cancer cell death by blocking Bcl-2 expression. This process involves the induction of BTG1, a key mediator of apoptosis regulated by Bcl-2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The antiapoptotic protein Bcl-2 is overexpressed in breast cancer, contributing to treatment resistance.
  • Bcl-2 inhibition is a potential strategy to sensitize cancer cells to chemotherapy.
  • Antisense oligonucleotides offer a method to inhibit Bcl-2 function.

Purpose of the Study:

  • To investigate the efficacy of antisense Bcl-2 oligonucleotides in inducing breast cancer cell apoptosis.
  • To identify downstream mediators of antisense Bcl-2-induced cytotoxicity.
  • To elucidate the role of B cell translocation gene 1 (BTG1) in this process.

Main Methods:

  • Treatment of breast cancer cells with antisense Bcl-2 oligonucleotides.
  • Assessment of Bcl-2 expression levels.
  • Evaluation of apoptosis induction and cell viability.
  • Knockdown and exogenous expression studies of BTG1.

Main Results:

  • Antisense Bcl-2 effectively reduced Bcl-2 expression, leading to breast cancer cell apoptosis.
  • Cytotoxicity induced by antisense Bcl-2 was linked to the upregulation of BTG1.
  • Knockdown of BTG1 attenuated the cytotoxic effects of antisense Bcl-2.
  • Bcl-2 negatively regulates BTG1 expression, and BTG1 overexpression induces apoptosis.

Conclusions:

  • BTG1 acts as a Bcl-2-regulated mediator of apoptosis in breast cancer.
  • Induction of BTG1 contributes to the cytotoxic effects of antisense Bcl-2 therapy.
  • Targeting Bcl-2 with antisense oligonucleotides represents a promising strategy for breast cancer treatment.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...